A. Boehler (Zurich, Switzerland), S. Keshavjee (Toronto, Canada)
Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients
E. Mamessier, F. Milhe, S. boniface, P. Dupuy, D. Vervloet, P. Thomas, A. Magnan, M. Reynaud-Gaubert (Marseille, France)
|  |
IL-6 promotor polymorphism (-174 C/G) and onset of bronchiolitis obliterans syndrome after lung transplantation
M. Hofer, T. Rechsteiner, E. W. Russi, A. Boehler (Zurich, Switzerland)
| |
Effects of posttransplant bronchiolitis obliterans syndrome (BOS) on exhaled nitric oxide (eNO)
A. Van Muylem, M. Estenne (Brussels, Belgium)
|  |
MMP-7 / MMP-9 in stable lung transplant recipients - a potential role in obliterative bronchiolitis
I. A. Forrest, C. Ward, G. Pritchard, A. D. Rowan, T. E. Cawston, P. A. Corris (Newcastle-upon-Tyne, United Kingdom)
| |
N-acetyl cysteine inhibits IL-17-induced IL-8 production from human airway smooth muscle cells - a possible role for anti-oxidant treatment in chronic lung rejection?
W. A. Wuyts, B. M. Vanaudenaerde, L. J. Dupont, D. E. Van Raemdonck, M. G. Demedts, G. M. Verleden (Leuven, Belgium)
| |
Hypo gammaglobulinemia (gG) after lung transplantation: impact of non specific gG replacement on infection and rejection
C. Pison, C. Découchon, B. Coltey, I. Pin, C. Chevallier, O. Chavanon, C. Sessa, D. Blin (Grenoble, France)
| |
Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
G. M. Verleden, L. J. Dupont, M. Delcroix, D. E. Van Raemdonck (Leuven, Belgium)
| |